Cargando…

613. Clinical Outcomes Following Dalbavancin Administration during Outpatient Parenteral Antimicrobial Therapy

BACKGROUND: Dalbavancin, a lipoglycopeptide with prolonged half-life targeting Gram-positive organisms, is approved for treatment of acute bacterial skin and soft tissue infection. It reduces hospital duration in patients with barriers to short-term rehabilitation or outpatient parenteral antimicrob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tuan, Jessica, Kayani, Jehanzeb, Fisher, Ann, Kotansky, Brian, Dembry, Louise, Datta, Rupak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643939/ http://dx.doi.org/10.1093/ofid/ofab466.811

Ejemplares similares

Clinical outcomes following dalbavancin administration in patients with barriers to outpatient parenteral antimicrobial therapy
por: Tuan, Jessica J., et al.
Publicado: (2022)

162. Assessment of Guideline-Concordant Testing for Legionella pneumophila and Streptococcus pneumoniae in Community-Acquired Pneumonia
por: Malik, Waleed, et al.
Publicado: (2022)

248. Antimicrobial Therapy for Suspected Urinary Tract Infection in Advanced Cancer Patients Transitioning to Comfort Measures
por: Wang, Tianyun, et al.
Publicado: (2018)

234. Dalbavancin versus Outpatient Parenteral Antimicrobial Therapy with Vancomycin for Treatment of Bone and Joint Infections in a Veteran Population
por: Gibbons, Emily A, et al.
Publicado: (2021)

1832. Concordance in End-of-Life Antimicrobial Prescribing Practices among Medicine Subspecialists
por: Datta, Rupak, et al.
Publicado: (2018)

2120. The Culture of Culturing Catheterized Patients: A Multi-Hospital Survey of Nurses and Physicians
por: Gao, Catherine, et al.
Publicado: (2018)

1162. An Evaluation of Metrics for Catheter-Associated Urinary Tract Infections (CAUTIs): A Statewide Comparison
por: Pepe, Dana, et al.
Publicado: (2019)

Comparison of traditional instruction versus nontraditional learning to improve trainee knowledge of urine culture practices in catheterized patients
por: Gao, Catherine A., et al.
Publicado: (2022)

Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy
por: Johnson, Tanner M., et al.
Publicado: (2023)

Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections
por: Bork, Jacqueline T., et al.
Publicado: (2019)

Adverse Events and Healthcare Utilization Associated With Outpatient Parenteral Antimicrobial Therapy Among Older Versus Younger Adults
por: Brzozowski, Kaylen, et al.
Publicado: (2020)

1932. Healthcare Utilization in Older vs. Younger Adults on Outpatient Parenteral Antimicrobial Therapy According to Discharge Location
por: Datta, Rupak, et al.
Publicado: (2018)

622. Evaluation of Vascular Access Device Selection in Patients Discharged on Outpatient Parenteral Antimicrobial Therapy
por: Hu, Jessica, et al.
Publicado: (2021)

597. Comparison of Vancomycin and Daptomycin Complications and Interventions in Outpatient Parenteral Antimicrobial Therapy
por: Nakrani, Monark, et al.
Publicado: (2020)

608. Impact of Implementing Pharmacist Review and Monitoring of Outpatient Parenteral Antimicrobial Therapy
por: Kirkpatrick, Emily R, et al.
Publicado: (2020)

623. Self-Administered Outpatient Parenteral Antimicrobial Therapy (S-OPAT) in Uninsured Patients
por: Hamad, Yasir, et al.
Publicado: (2020)

Paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): An e-survey of the experiences of parents and clinicians
por: Carter, Bernie, et al.
Publicado: (2021)

754. Evaluation of Standardized Dalbavancin Use to Facilitate Early Hospital Discharge for Patients Inappropriate for Outpatient Parenteral Antibiotic Therapy
por: Shihadeh, Katherine C, et al.
Publicado: (2019)

OPAT: outpatient parenteral antimicrobial therapy
Publicado: (2020)

Outpatient parenteral antimicrobial therapy in Brazil
por: Oliveira, Priscila R, et al.
Publicado: (2023)

601. Assessment of a Nursing and Pharmacy Collaborative Outpatient Parenteral Antimicrobial Therapy Management Program
por: Hemenway, Alice N, et al.
Publicado: (2021)

608. Continuous Infusion Vancomycin Is Not Associated with Improved Safety in an Outpatient Parenteral Antimicrobial Therapy Program
por: Tagare, Rosemarie D, et al.
Publicado: (2021)

Dalbavancin: a novel antimicrobial
por: Chen, A Y, et al.
Publicado: (2007)

610. Incidence of Acute Kidney Injury in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Vancomycin
por: Hamad, Yasir, et al.
Publicado: (2020)

604. Factors Associated with Adverse Drug Reactions Leading to Discontinuation of Vancomycin in Outpatient Parenteral Antimicrobial Therapy
por: McDonald, Josh, et al.
Publicado: (2020)

600. Decreased Hospital Readmission After Programmatic Strengthening of an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program
por: Agnihotri, Gaurav, et al.
Publicado: (2020)

622. Risk Factors for 30-Day Unplanned Readmissions in Patients Discharged with Outpatient Parenteral Antimicrobial Therapy
por: Shah, Megan, et al.
Publicado: (2020)

126. evaluation of Addition of Outpatient Parenteral Antimicrobial Therapy and Orthopedic ID Resources to Transitions-of-care Outcomes
por: Young, Brett, et al.
Publicado: (2020)

1935. Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Blaskewicz, Caitlin, et al.
Publicado: (2018)

Safety of Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Shrestha, Nabin K, et al.
Publicado: (2020)

Recommendations for outpatient parenteral antimicrobial therapy in Brazil
por: Oliveira, Priscila R., et al.
Publicado: (2017)

Being ‘at-home’ on outpatient parenteral antimicrobial therapy (OPAT): a qualitative study of parents’ experiences of paediatric OPAT
por: Carter, Bernie, et al.
Publicado: (2020)

Knowledge and Practices of Physicians and Nurses Related to Urine Cultures in Catheterized Patients: An Assessment of Adherence to IDSA Guidelines
por: Advani, Sonali D, et al.
Publicado: (2019)

Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy
por: Mahoney, Monica V., et al.
Publicado: (2021)

602. Do These Labs Really Matter? Searching for the Benefit of Laboratory Monitoring in Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Zukauckas, Kelsea N, et al.
Publicado: (2020)

620. Identifying the Role for a Pharmacist on an Outpatient Parenteral Antimicrobial Therapy (OPAT) Team in an Academic Teaching Hospital
por: Hino, Garret H, et al.
Publicado: (2021)

537. Outpatient Parenteral Antimicrobial Therapy Readmissions from Post-Acute Care Facilities due to Coronavirus Disease 2019
por: Burnett, Yvonne, et al.
Publicado: (2020)

Granulicatella adiacens and Early-Onset Sepsis in Neonate
por: Bizzarro, Matthew J., et al.
Publicado: (2011)

Evaluation of Inpatient Antimicrobial Regimens for Readmitted Outpatient Parenteral Antimicrobial Therapy Patients Receiving Daptomycin or Ertapenem for Ease of Administration
por: Britt, Rachel S, et al.
Publicado: (2019)

Successful Establishment of an Antimicrobial Stewardship Program (ASP) for Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Nathan, Ramesh V, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dd4cq79aobqfmu16fc8vi6lea9